VOLPE, Annibale
 Distribuzione geografica
Continente #
NA - Nord America 54.096
AS - Asia 23.543
EU - Europa 20.582
SA - Sud America 3.713
Continente sconosciuto - Info sul continente non disponibili 478
AF - Africa 465
OC - Oceania 60
Totale 102.937
Nazione #
US - Stati Uniti d'America 53.169
GB - Regno Unito 7.895
CN - Cina 6.952
SG - Singapore 6.723
HK - Hong Kong 3.075
IT - Italia 2.943
BR - Brasile 2.875
VN - Vietnam 2.231
DE - Germania 2.025
SE - Svezia 1.841
UA - Ucraina 1.509
FI - Finlandia 1.258
BD - Bangladesh 1.085
RU - Federazione Russa 856
TR - Turchia 844
KR - Corea 772
FR - Francia 714
BG - Bulgaria 529
CA - Canada 442
IN - India 441
AR - Argentina 305
ID - Indonesia 263
MX - Messico 212
NL - Olanda 177
IQ - Iraq 165
EC - Ecuador 141
PL - Polonia 132
PK - Pakistan 122
JP - Giappone 121
ZA - Sudafrica 120
AE - Emirati Arabi Uniti 115
CO - Colombia 106
IE - Irlanda 96
ES - Italia 93
VE - Venezuela 91
MY - Malesia 86
CL - Cile 72
MA - Marocco 69
PH - Filippine 69
UZ - Uzbekistan 57
CR - Costa Rica 55
SA - Arabia Saudita 55
EG - Egitto 53
AT - Austria 52
JM - Giamaica 51
LT - Lituania 48
TH - Thailandia 46
AU - Australia 45
KE - Kenya 43
BE - Belgio 40
PY - Paraguay 37
CZ - Repubblica Ceca 36
TN - Tunisia 35
NP - Nepal 33
CH - Svizzera 32
DK - Danimarca 32
IR - Iran 31
JO - Giordania 31
BY - Bielorussia 30
DZ - Algeria 30
PT - Portogallo 30
UY - Uruguay 30
PE - Perù 29
EU - Europa 27
GR - Grecia 27
KZ - Kazakistan 26
BO - Bolivia 24
RO - Romania 24
TT - Trinidad e Tobago 24
AZ - Azerbaigian 23
NG - Nigeria 22
DO - Repubblica Dominicana 21
AL - Albania 20
IL - Israele 19
TW - Taiwan 19
HR - Croazia 18
LV - Lettonia 18
RS - Serbia 18
HU - Ungheria 17
NI - Nicaragua 17
ET - Etiopia 16
HN - Honduras 16
SI - Slovenia 16
OM - Oman 15
PA - Panama 15
BH - Bahrain 14
BZ - Belize 14
NZ - Nuova Zelanda 13
PS - Palestinian Territory 13
GE - Georgia 12
GT - Guatemala 12
LB - Libano 12
MN - Mongolia 12
XK - ???statistics.table.value.countryCode.XK??? 12
BB - Barbados 11
CY - Cipro 11
KG - Kirghizistan 11
NO - Norvegia 11
SV - El Salvador 11
SC - Seychelles 10
Totale 102.316
Città #
Southend 5.970
Fairfield 4.722
Ashburn 4.572
Singapore 4.177
Santa Clara 3.945
Jacksonville 3.284
Woodbridge 3.118
Hong Kong 3.021
Houston 2.528
Hefei 2.506
Dearborn 1.974
Wilmington 1.866
Chandler 1.792
Ann Arbor 1.783
Seattle 1.741
San Jose 1.723
Cambridge 1.546
Beijing 1.248
London 1.204
Council Bluffs 1.186
Los Angeles 1.000
Nyköping 964
Chicago 944
The Dalles 795
Seoul 730
Helsinki 728
Ho Chi Minh City 715
Modena 606
Princeton 598
Hanoi 540
Sofia 519
Eugene 500
Buffalo 453
Milan 453
San Diego 441
New York 429
Lauterbourg 427
Dallas 422
Columbus 392
Izmir 386
Salt Lake City 372
Bremen 261
São Paulo 247
Shanghai 245
Moscow 240
Tampa 184
Des Moines 158
Elk Grove Village 151
Rome 141
Guangzhou 125
Frankfurt am Main 124
Jakarta 118
Orem 118
Phoenix 116
Haiphong 107
Atlanta 99
Norwalk 98
Falls Church 92
Da Nang 90
Dublin 89
Philadelphia 89
Munich 88
Lancaster 87
Tokyo 86
San Francisco 81
Redwood City 80
Rio de Janeiro 80
Miano 76
Brooklyn 75
Toronto 75
Miami 73
Vancouver 73
Sterling 72
Warsaw 71
Mexico City 70
Nanjing 69
Denver 68
Boardman 67
Chennai 67
Kunming 62
Dulles 61
Biên Hòa 59
Baghdad 58
Quito 58
Belo Horizonte 56
Montreal 55
Naples 55
Amsterdam 53
Brasília 53
Curitiba 52
Manchester 51
San Mateo 51
Tashkent 51
Dubai 50
Falkenstein 48
Detroit 47
Porto Alegre 47
Kansas City 46
Charlotte 44
Bologna 42
Totale 71.669
Nome #
Nimesulide in the treatment of primary dysmenorrhea: A double-blind study versus diclofenac 840
Diurnal variation of semen quality in human males. 682
NEUROENDOCRINOLOGY OF THE HUMAN PLACENTA 673
Sonographic early fetal gender assignment: a longitudinal study in pregnancies after in vitro fertilization. 609
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 549
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 520
Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. 511
Anti-Mullerian hormone (AMH): what do we still need to know? 484
A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: An open, randomized, cross-over trial 438
L-arginine supplementation in patients with gestational hypertension: A pilot study 433
Intensity of menstrual pain and estimated angle of uterine flexion 415
An increased vulnerability to stress is associated with a poor outcome of in vitro fertilization-embryo transfer treatment 399
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 396
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 394
Reduction of serum citrulline levels in women at term toward the day of labor onset 383
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 381
Increased L-citrulline/L-arginine plasma ratio in severe preeclampsia. 381
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 375
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 373
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 365
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 359
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 350
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 349
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 347
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 347
Effects of L-arginine on utero-placental circulation in growth-retarded fetuses 346
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 340
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 338
Intermenstrual pelvic pain, quality of life and mood 338
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 334
Serum nitrites predict the response to prostaglandin-induced delivery at term 333
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 332
Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term. 331
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: Perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project) 331
Computerized Evaluation of Fetal Heart Rate during Tocolytic Treatment: Comparison between Atosiban and Ritodrine. 329
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 329
Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate 328
Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients 326
17α-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery 325
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 322
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 322
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 322
The dramatic COVID-19 outbreak in italy is responsible of a huge drop in urological surgical activity: A multicenter observational study 322
Pharmacokinetic evaluation of desogestrel as a female contraceptive 321
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 320
Periodontal disease and nitric oxide levels in low risk women with preterm labor 317
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 317
1076 Independent validation of the 2010 TNM staging system for renal cell carcinoma : does it improves predictive accuracy in cancer-specific mortality compared to 2002 TNM? 317
Comparison of two preparations of dinoprostone for pre-induction of labour in iparous women with very unfavourable cervical condition: a randomised clinical trial 314
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 313
A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. 312
Color Doppler and hormone replacement therapy: the role of thromboxane and plasma viscosity 311
Benefits and risks of different hormonal replacement therapies in post-menopausal women. 310
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 308
Primary ovarian insufficiency: autoimmune causes. 305
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 301
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 298
Season of birth influences the timing of menopause 297
The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study 296
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 296
Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases 296
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 295
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 291
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 291
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 290
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 289
24 HOURS AMBULATORY BLOOD PRESSURE MONITORING: A COMPARISON BETWEEN TRANSDERMAL GLICERYL-TRINITRATE AND ORAL NIFEDIPINE 287
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 287
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 286
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 286
The L-arginine-nitric oxide system regulates platelet aggregation in pregnancy 285
Ripening of the cervix with sodium nitroprusside in nonpregnant women. 284
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 284
L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release 280
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 280
The ovarian follicular pool and reproductive outcome in women. 276
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 275
EFFICACY ON HYPERANDROGENISM AND SAFETY OF A NEW ORAL-CONTRACEPTIVE BIPHASIC FORMULATION CONTAINING DESOGESTREL 274
Oral discomfort and hormone replacement therapy in the post-menopause. 272
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 271
Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy 271
Oestradiol/progesterone imbalance and the premenstrual syndrome. 271
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 270
Metformin treatment of PCOS during adolescence and the reproductive period 268
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 268
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 267
Non-stress test changes during acupuncture plus moxibustion on BL67 point in breech presentation. 266
ELECTIVE CERVICAL RIPENING IN WOMEN BEYOND THE 290TH DAY OF PREGNANCY: A RANDOMIZED TRIAL COMPARING 2 DINOPROSTONE PREPARATIONS. 265
Perimenopausal risk factors and future health. 265
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 262
Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomized controlled trial. 262
Early prenatal diagnosis of recurrent 46,XY partial gonadal dysgenesis. 262
Allergic reaction to a highly purified urinary follicle stimulating hormone preparation in controlled ovarian hyperstimulation for in vitro fertilization 261
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 260
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 260
A role for melatonin in PCOS? 255
Serum anti-Mullerian hormone throughout the human menstrual cycle 255
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 255
Prevalence of menstrual pain in young women: What is dysmenorrhea? 254
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 254
Totale 33.484
Categoria #
all - tutte 401.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 401.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.830 0 0 876 487 190 270 494 336 760 465 938 1.014
2022/20235.652 803 564 298 418 868 878 106 491 730 68 216 212
2023/20244.052 127 217 183 327 1.000 447 590 468 79 85 137 392
2024/202514.077 438 159 100 1.035 2.792 1.829 540 735 1.926 1.235 1.364 1.924
2025/202631.552 1.702 1.407 3.504 4.054 4.152 1.917 3.369 1.745 2.543 3.057 2.008 2.094
2026/20275.588 1.789 2.431 1.368 0 0 0 0 0 0 0 0 0
Totale 102.937